ACCURAY INCORPORATED Royalty Expense
ACCURAY INCORPORATED (ARAY) reported Royalty Expense of $1.50 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-08-27
- ACCURAY INCORPORATED royalty expense for the quarter ending 2026-06-30 was $424.00K, a 7.89% increase year-over-year.
- ACCURAY INCORPORATED royalty expense for the quarter ending 2026-03-31 was $388.00K, a 26.52% decline year-over-year.
- ACCURAY INCORPORATED royalty expense for the quarter ending 2025-12-31 was $358.00K, a 35.14% decline year-over-year.
- ACCURAY INCORPORATED royalty expense for the quarter ending 2025-09-30 was $328.00K, a 34.98% increase year-over-year.
- ACCURAY INCORPORATED royalty expense for fiscal 2026 was $1.50M, a 12.76% decline from fiscal 2025.
- ACCURAY INCORPORATED royalty expense for fiscal 2025 was $1.72M, a 10.30% decline from fiscal 2024.
- ACCURAY INCORPORATED royalty expense for fiscal 2024 was $1.91M.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $812.00K derived: sum of 2 quarters · filed 2026-08-27 | $1.17M derived: sum of 3 quarters · filed 2026-08-27 | $1.50M 10-K · filed 2026-08-27 |
| 2026-03-31 | $388.00K 10-Q · filed 2026-05-06 | $746.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.07M 10-Q · filed 2026-05-06 | $1.47M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-12-31 | $358.00K 10-Q · filed 2026-02-17 | $686.00K 10-Q · filed 2026-02-17 | $1.08M derived: sum of 3 quarters · filed 2026-08-27 | $1.61M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-09-30 | $328.00K 10-Q/A · filed 2026-02-17 | $721.00K derived: sum of 2 quarters · filed 2026-08-27 | $1.25M derived: sum of 3 quarters · filed 2026-08-27 | $1.80M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-06-30 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $921.00K derived: sum of 2 quarters · filed 2026-08-27 | $1.47M derived: sum of 3 quarters · filed 2026-08-27 | $1.72M 10-K · filed 2026-08-27 |
| 2025-03-31 | $528.00K 10-Q · filed 2026-05-06 | $1.08M derived: sum of 2 quarters · filed 2026-05-06 | $1.32M 10-Q · filed 2026-05-06 | $1.91M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $552.00K 10-Q · filed 2026-02-17 | $795.00K 10-Q · filed 2026-02-17 | $1.38M derived: sum of 3 quarters · filed 2026-02-17 | $1.77M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $243.00K 10-Q/A · filed 2026-02-17 | $825.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.22M derived: sum of 3 quarters · filed 2026-02-17 | $1.65M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $582.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-02-17 | $976.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.40M derived: sum of 3 quarters · filed 2026-02-17 | $1.91M 10-K/A · filed 2026-02-17 |
| 2024-03-31 | $394.00K 10-Q · filed 2025-05-02 | $822.00K derived: sum of 2 quarters · filed 2025-05-02 | $1.33M 10-Q · filed 2025-05-02 | |
| 2023-12-31 | $428.00K 10-Q · filed 2025-02-05 | $937.00K 10-Q · filed 2025-02-05 | ||
| 2023-09-30 | $509.00K 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |